|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation of property and equipment | |||||
| Gain on sale of property and equipment | |||||
| Bad debt expense | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Amortization of intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Trade accounts receivable, net | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Income taxes | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from debt obligations | |||||
| Payments against debt obligations | |||||
| Proceeds from exercise of stock options | |||||
| Purchases of common stock | |||||
| Cash dividends paid | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental information: | |||||
| Cash paid for interest | |||||
| Net cash paid for income taxes | |||||
Loading...